Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Aromatase inhibitors and bone loss.
Perez EA, Weilbaecher K. Perez EA, et al. Among authors: weilbaecher k. Oncology (Williston Park). 2006 Aug;20(9):1029-39; discussion 1039-40, 1042, 1048. Oncology (Williston Park). 2006. PMID: 16986348 Free PMC article. Review.
Skeletal complications of breast cancer therapies.
Hirbe A, Morgan EA, Uluçkan O, Weilbaecher K. Hirbe A, et al. Among authors: weilbaecher k. Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6309s-6314s. doi: 10.1158/1078-0432.CCR-06-0652. Clin Cancer Res. 2006. PMID: 17062720 Free PMC article. Review.
Advances in treating metastatic bone cancer: summary statement for the First Cambridge Conference.
Lipton A, Berenson JR, Body JJ, Boyce BF, Bruland OS, Carducci MA, Cleeland CS, Clohisy DR, Coleman RE, Cook RJ, Guise TA, Pearse RN, Powles TJ, Rogers MJ, Roodman GD, Smith MR, Suva LJ, Vessella RL, Weilbaecher KN, King L. Lipton A, et al. Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6209s-6212s. doi: 10.1158/1078-0432.CCR-06-1213. Clin Cancer Res. 2006. PMID: 17062702 Free PMC article.
The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects.
Hurchla MA, Garcia-Gomez A, Hornick MC, Ocio EM, Li A, Blanco JF, Collins L, Kirk CJ, Piwnica-Worms D, Vij R, Tomasson MH, Pandiella A, San Miguel JF, Garayoa M, Weilbaecher KN. Hurchla MA, et al. Among authors: weilbaecher kn. Leukemia. 2013 Feb;27(2):430-40. doi: 10.1038/leu.2012.183. Epub 2012 Jul 5. Leukemia. 2013. PMID: 22763387 Free PMC article.
Disruption of CXCR4 enhances osteoclastogenesis and tumor growth in bone.
Hirbe AC, Rubin J, Uluçkan O, Morgan EA, Eagleton MC, Prior JL, Piwnica-Worms D, Weilbaecher KN. Hirbe AC, et al. Proc Natl Acad Sci U S A. 2007 Aug 28;104(35):14062-7. doi: 10.1073/pnas.0705203104. Epub 2007 Aug 22. Proc Natl Acad Sci U S A. 2007. PMID: 17715292 Free PMC article.
Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial.
Aft R, Naughton M, Trinkaus K, Watson M, Ylagan L, Chavez-MacGregor M, Zhai J, Kuo S, Shannon W, Diemer K, Herrmann V, Dietz J, Ali A, Ellis M, Weiss P, Eberlein T, Ma C, Fracasso PM, Zoberi I, Taylor M, Gillanders W, Pluard T, Mortimer J, Weilbaecher K. Aft R, et al. Among authors: weilbaecher k. Lancet Oncol. 2010 May;11(5):421-8. doi: 10.1016/S1470-2045(10)70054-1. Epub 2010 Mar 31. Lancet Oncol. 2010. PMID: 20362507 Free PMC article. Clinical Trial.
Cancer to bone: a fatal attraction.
Weilbaecher KN, Guise TA, McCauley LK. Weilbaecher KN, et al. Nat Rev Cancer. 2011 Jun;11(6):411-25. doi: 10.1038/nrc3055. Epub 2011 May 19. Nat Rev Cancer. 2011. PMID: 21593787 Free PMC article. Review.
119 results